Latest / Stock Movers / SpaceX Falls, Eli Lilly Jumps, Davita Slides as US Dialysis Revenue Misses Estimates
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News.
- 0:08Speaker 2: The Stock Movers report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg data recording,
- 0:17Speaker 2: we've factoring on the screen all those stocks are off
- 0:19Speaker 2: their highs but still holding on some gains.
- 0:21Speaker 1: To take a look at some of the stocks on
- 0:22Speaker 1: the move today, and we can do that with that
- 0:24Speaker 1: line for now Equities reporter for Bloomberg News joining us
- 0:26Speaker 1: live here in studio alone. What are you looking at?
- 0:28Speaker 3: We have to start off with spacexets ticker SPCX. It's
- 0:31Speaker 3: currently falling about eight point two percent, most since July first,
- 0:35Speaker 3: and that' stuffed a company's first earnings release left investors
- 0:38Speaker 3: wanting a little bit more. At issue was higher than
- 0:40Speaker 3: expected spending in the company's AI unit, which really weighed
- 0:44Speaker 3: on cash flow. Capex stored to nearly twenty nine billion
- 0:47Speaker 3: dollars in the first half of this year, which is
- 0:49Speaker 3: more than four times at spending just a year earlier.
- 0:52Speaker 3: Oppenheimer highlighting that the capex levels are a major concern
- 0:55Speaker 3: for investors, especially considering that SpaceX will need more than
- 0:59Speaker 3: four hundred billion dollars in funding to hit break even.
- 1:02Speaker 3: Piper Sandler, also adding that the lock up expiration is
- 1:04Speaker 3: also contributing to stock weakness today, so we'll definitely be
- 1:07Speaker 3: keeping an eye on it tomorrow as those one hundred
- 1:09Speaker 3: and one billion dollars worth of shares become available for
- 1:12Speaker 3: trading tomorrow.
- 1:12Speaker 1: Yeah, definitely another headwind for this stock that remain as
- 1:16Speaker 1: well below the one thirty five IPO price. All right,
- 1:18Speaker 1: let's stick with the earning season theme. Yes, Eli Lilly.
- 1:21Speaker 3: That's ticker LLY. It was up nearly nine percent earlier
- 1:26Speaker 3: but now only up about two point two percent. That's
- 1:28Speaker 3: after the firm's better than expected second quarter results led
- 1:31Speaker 3: to a boost in twenty twenty six sales guidance BMO,
- 1:34Speaker 3: highlighting that Lily again raised the bar with another beat
- 1:37Speaker 3: and raised quarter, also noting that the relatively inline quarter
- 1:40Speaker 3: for Lily's weight loss pill FOUNDEO is also likely sufficient
- 1:44Speaker 3: given declining expectations for the drug Worf, noting that these
- 1:47Speaker 3: results are definitely going to suage some fears from investors
- 1:50Speaker 3: at the obest drug boom is starting to slow down,
- 1:53Speaker 3: especially after their rival Novo Nordis reported a little bit
- 1:56Speaker 3: softer will go be pill sales?
- 1:58Speaker 1: Last one here I don't know. DaVita Davida.
- 2:01Speaker 3: Yes, DaVita is definitely something that we will also be
- 2:05Speaker 3: talking about. That's tickert DVA. It fell nearly nineteen percent
- 2:09Speaker 3: today and that's partially because their US dialysis revenue missed estimates.
- 2:15Speaker 3: Part of that is definitely because of their treatment center growth.
- 2:19Speaker 3: Barclay is actually pointing out that while they have made
- 2:21Speaker 3: a lot of progress on treatment growth, the US dialysis
- 2:24Speaker 3: ebit continues to fall short, and that's definitely ahead when
- 2:27Speaker 3: that people will be watching. Also worth noting that the
- 2:30Speaker 3: firm reaffirmed it is for your guidance, with the midpoint
- 2:33Speaker 3: of that guidance now falling below Wall Street's expectations as well.
- 2:36Speaker 1: All right, Avalon, thank you so much for that wrap
- 2:39Speaker 1: up of Stocks on the Move.
- 2:41Speaker 2: The Stock Movers Report from Bloomberg Radio. Check back with
- 2:45Speaker 2: us throughout the day for the latest roundup of companies
- 2:48Speaker 2: making news on Wall Street and for the latest market
- 2:51Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 2:56Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 2:59Speaker 2: the Bloomberg Business app.